Optivise Advisory Services
CVS icon

Optivise Advisory Services’s CVS Health CVS Stock Holding History

Optivise Advisory Services’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$343K Buy
3,998
+5
+0.1% +$490 0.17% 145
2026
Q2 		$413K Buy
3,993
+7
+0.2% +$625 0.21% 130
2026
Q1 		$286K Sell
3,986
-3
-0.1% -$231 0.17% 135
2025
Q4 		$317K Sell
3,989
-8
-0.2% -$631 0.18% 133
2025
Q3 		$301K Buy
3,997
+51
+1% +$3.5K 0.18% 128
2025
Q2 		$272K Sell
3,946
-5
-0.1% -$328 0.14% 150
2025
Q1 		$268K Buy
+3,951
New +$236K 0.15% 143
2024
Q4 		– Sell
-4,112
Closed -$259K – 183
2024
Q3 		$259K Buy
4,112
+282
+7% +$16.5K 0.14% 136
2024
Q2 		$226K Buy
+3,830
New +$240K 0.12% 163

Other funds holding CVS

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Canoe Financial
Canoe Financial Calgary, Alberta, Canada $8.31B AUM 20.77% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return

Optivise Advisory Services's CVS Position: Q3 2026 in Review

Optivise Advisory Services increased its CVS Health (CVS) stake by 0.13% in Q3 2026, buying an estimated $490 and bringing the position to 3,998 shares worth $343K. The position accounts for 0.17% of the portfolio, ranked #145.

Optivise Advisory Services first reported a position in CVS in Q2 2024 and has held it in 9 quarters since. The position peaked at $413K in Q2 2026. 759 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • Optivise Advisory Services held 3,998 shares of CVS Health worth $343K as of Q3 2026.
  • Optivise Advisory Services bought 5 CVS Health shares in Q3 2026, an estimated $490.
  • CVS Health made up 0.17% of Optivise Advisory Services's portfolio in Q3 2026, its #145 holding.
  • Optivise Advisory Services first reported a position in CVS Health in Q2 2024 and has held it in 9 quarters since.
  • Optivise Advisory Services's CVS Health position peaked at $413K in Q2 2026.
  • 759 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Optivise Advisory Services's 13F filing for Q3 2026, filed 19 Oct 2026.